Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy

Update Il y a 4 ans
Reference: NCT00686036

  • | Country :
  • Canada
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine whether treatment with Zactima for up to 18 months will prolong the off-treatment interval in patients who are undergoing intermittent androgen deprivation therapy.


Inclusion criteria

  • Prostate cancer

Links